Earnings Estimates Rising for Alnylam (ALNY): Will It Gain?

Investors might want to bet on Alnylam Pharmaceuticals (ALNY) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this RNA interference drug developer, should get reflected in its stock price. After all, empirical research shows a ...